For the Inventor, By the Inventor

Enter assignee name

Newtown, PA, United States of America

Onconova Therapeutics, Inc.

USPTO Granted Patents = 19

% Expired Patents = 36.8

CIPO Patents = 4

EPO Patents = 15

Forward Citations = 48

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Stanley Charles Bell (13 out of 55 patents)

M V Ramana Reddy (9 out of 45 patents)

Manoj Maniar (8 out of 12 patents)

4. E Premkumar Reddy (5 out of 45 patents)

5. Azra Raza (1 out of 2 patents)

6. Francois Wilhelm (1 out of 1 patent)

7. Ramesh Kumar (1 out of 10 patents)

8. Glenn J Fegley (1 out of 3 patents)

9. Stephen Cosenza (1 out of 4 patents)

10. Jodie Duke (1 out of 2 patents)

11. Reddy E Premkumar (1 out of 1 patent)

12. Reddy M V Ramana (1 out of 1 patent)

13. Albert Wong (1 out of 1 patent)

14. Mv Ramana Reddy (1 out of 3 patents)

15. Lawrence Helson (22 patents)

19 patents: Sort by Forward Citations

1. 11382877 - Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability (2022-07-12),

2. 10576050 - Methods and compositions for treatment of cancer (2020-03-03),

3. 10098862 - Formulations with enhanced stability and bioavailability for administration of (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones (2018-10-16),

4. 9713597 - Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone (2017-07-25),

5. 9060967 - Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone (2015-06-23),

6. 9044427 - Compositions and methods for prevention and treatment of wounds (2015-06-02),

7. 8476320 - Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones (2013-07-02),

8. 8324190 - Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones (2012-12-04),

9. 8273787 - Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions (2012-09-25),

10. 8143453 - Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis (2012-03-27),

11. 8063109 - Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones (2011-11-22),

12. 7932242 - Substituted phenoxy-and phenylthio-derivatives for treating proliferative disorders (2011-04-26),

13. 7598232 - [object Object] (2009-10-06),

14. 7161031 - Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders (2007-01-09),

15. 7094903 - Processes for the preparation of substituted isoxazoles and 2-isoxazolines (2006-08-22),

Company Overview

Onconova Therapeutics, Inc. is a biopharmaceutical company based in Newtown, Pennsylvania, focused on developing innovative therapies for cancer treatment. The company specializes in novel drug candidates that target specific pathways involved in cancer cell proliferation and survival. With a commitment to advancing oncology care, Onconova leverages its proprietary technology platforms to create targeted therapies aimed at improving patient outcomes in various cancer types. Their research efforts are dedicated to addressing unmet medical needs in the oncology landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

19 Patents

#5 in Newtown, PA

#627 in Pennsylvania

#17,138 in US

#32,663 in the World

Newtown, PA, United States of America

Onconova Therapeutics, Inc.

Forward Citations = 48

14 inventors:

Stanley Charles Bell (13 out of 55 patents)

M V Ramana Reddy (9 out of 45 patents)

Manoj Maniar (8 out of 12 patents)

4. E Premkumar Reddy (5 out of 45 patents)

5. Azra Raza (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Onconova Therapeutics, Inc.. Retrieved from https://idiyas.com/company/onconova-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…